793 related articles for article (PubMed ID: 19732874)
1. Inadvertent recombinant human follicle stimulating hormone bolus instead of human chorionic gonadotrophin leads to the retrieval of competent oocytes in IVF program.
Bianchi V; Dal Prato L; Maccolini A; Mazzone S; Borini A
Fertil Steril; 2009 Nov; 92(5):1747.e1-3. PubMed ID: 19732874
[TBL] [Abstract][Full Text] [Related]
2. A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer.
Propst AM; Bates GW; Robinson RD; Arthur NJ; Martin JE; Neal GS
Fertil Steril; 2006 Jul; 86(1):58-63. PubMed ID: 16753156
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of recombinant versus human derived follicle stimulating hormone on the oocyte and embryo quality in IVF-ICSI cycles: Randomised, controlled, multi-centre trial.
Abate A; Nazzaro A; Salerno A; Marzano F; Pavone Cossut MR; Perino M
Gynecol Endocrinol; 2009 Aug; 25(8):479-84. PubMed ID: 19572228
[TBL] [Abstract][Full Text] [Related]
4. In vivo maturation of oocytes by extending the interval between human chorionic gonadotropin administration and oocyte retrieval.
Raziel A; Schachter M; Strassburger D; Kasterstein E; Ron-El R; Friedler S
Fertil Steril; 2006 Sep; 86(3):583-7. PubMed ID: 16828475
[TBL] [Abstract][Full Text] [Related]
5. Ovarian stimulation protocols based on follicle-stimulating hormone glycosylation pattern: impact on oocyte quality and clinical outcome.
Selman H; Pacchiarotti A; El-Danasouri I
Fertil Steril; 2010 Oct; 94(5):1782-6. PubMed ID: 19939369
[TBL] [Abstract][Full Text] [Related]
6. Ovarian stimulation with daily late follicular phase administration of low-dose human chorionic gonadotropin for in vitro fertilization: a prospective, randomized trial.
Serafini P; Yadid I; Motta EL; Alegretti JR; Fioravanti J; Coslovsky M
Fertil Steril; 2006 Oct; 86(4):830-8. PubMed ID: 16963040
[TBL] [Abstract][Full Text] [Related]
7. Clinical effects of ovulation induction with recombinant follicle-stimulating hormone supplemented with recombinant luteinizing hormone or low-dose recombinant human chorionic gonadotropin in the midfollicular phase in microdose cycles in poor responders.
Berkkanoglu M; Isikoglu M; Aydin D; Ozgur K
Fertil Steril; 2007 Sep; 88(3):665-9. PubMed ID: 17292895
[TBL] [Abstract][Full Text] [Related]
8. Natural-cycle in vitro fertilization combined with in vitro maturation of immature oocytes is a potential approach in infertility treatment.
Chian RC; Buckett WM; Abdul Jalil AK; Son WY; Sylvestre C; Rao D; Tan SL
Fertil Steril; 2004 Dec; 82(6):1675-8. PubMed ID: 15589878
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of highly purified human menopausal gonadotropin vs. recombinant follicle-stimulating hormone in first-cycle in vitro fertilization-intracytoplasmic sperm injection patients.
Hompes PG; Broekmans FJ; Hoozemans DA; Schats R;
Fertil Steril; 2008 Jun; 89(6):1685-93. PubMed ID: 17681325
[TBL] [Abstract][Full Text] [Related]
10. Comparison of serum and follicular fluid hormone levels with recombinant and urinary human chorionic gonadotropin during in vitro fertilization.
Kovacs P; Kovats T; Bernard A; Zadori J; Szmatona G; Kaali SG
Fertil Steril; 2008 Dec; 90(6):2133-7. PubMed ID: 18177866
[TBL] [Abstract][Full Text] [Related]
11. In vitro maturation of germinal vesicle oocytes recovered after premature luteinizing hormone surge: description of a novel approach to fertility preservation.
Oktay K; Demirtas E; Son WY; Lostritto K; Chian RC; Tan SL
Fertil Steril; 2008 Jan; 89(1):228.e19-22. PubMed ID: 17517403
[TBL] [Abstract][Full Text] [Related]
12. Exposure to human chorionic gonadotropin during in vitro maturation does not improve the maturation rate and developmental potential of immature oocytes from patients with polycystic ovary syndrome.
Ge HS; Huang XF; Zhang W; Zhao JZ; Lin JJ; Zhou W
Fertil Steril; 2008 Jan; 89(1):98-103. PubMed ID: 17524398
[TBL] [Abstract][Full Text] [Related]
13. Dual trigger with gonadotropin-releasing hormone agonist and standard dose human chorionic gonadotropin to improve oocyte maturity rates.
Griffin D; Feinn R; Engmann L; Nulsen J; Budinetz T; Benadiva C
Fertil Steril; 2014 Aug; 102(2):405-9. PubMed ID: 24842671
[TBL] [Abstract][Full Text] [Related]
14. In vitro maturation for patients with repeated in vitro fertilization failure due to "oocyte maturation abnormalities".
Hourvitz A; Maman E; Brengauz M; Machtinger R; Dor J
Fertil Steril; 2010 Jul; 94(2):496-501. PubMed ID: 19589517
[TBL] [Abstract][Full Text] [Related]
15. Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles.
Barrenetxea G; Agirregoikoa JA; Jiménez MR; de Larruzea AL; Ganzabal T; Carbonero K
Fertil Steril; 2008 Mar; 89(3):546-53. PubMed ID: 17531989
[TBL] [Abstract][Full Text] [Related]
16. Blastocyst formation, pregnancy, and birth derived from human oocytes cryopreserved for 5 years.
Parmegiani L; Fabbri R; Cognigni GE; Bernardi S; Pocognoli P; Filicori M
Fertil Steril; 2008 Nov; 90(5):2014.e7-10. PubMed ID: 18402940
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of recombinant human follicle-stimulating hormone in improving oocyte quality in assisted reproductive techniques.
Cheon KW; Byun HK; Yang KM; Song IO; Choi KH; Yoo KJ
J Reprod Med; 2004 Sep; 49(9):733-8. PubMed ID: 15493565
[TBL] [Abstract][Full Text] [Related]
18. A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists.
Kolibianakis EM; Schultze-Mosgau A; Schroer A; van Steirteghem A; Devroey P; Diedrich K; Griesinger G
Hum Reprod; 2005 Oct; 20(10):2887-92. PubMed ID: 15979994
[TBL] [Abstract][Full Text] [Related]
19. Clinical efficacy of highly purified urinary FSH versus recombinant FSH in volunteers undergoing controlled ovarian stimulation for in vitro fertilization: a randomized, multicenter, investigator-blind trial.
Baker VL; Fujimoto VY; Kettel LM; Adamson GD; Hoehler F; Jones CE; Soules MR
Fertil Steril; 2009 Apr; 91(4):1005-11. PubMed ID: 18367182
[TBL] [Abstract][Full Text] [Related]
20. Lower apoptosis rate in human cumulus cells after administration of recombinant luteinizing hormone to women undergoing ovarian stimulation for in vitro fertilization procedures.
Ruvolo G; Bosco L; Pane A; Morici G; Cittadini E; Roccheri MC
Fertil Steril; 2007 Mar; 87(3):542-6. PubMed ID: 17126339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]